- Home
- RIOT vs ACLX Comparison
RIOT vs ACLX Comparison
Compare RIOT & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIOT
- ACLX
- Stock Information
- Founded
- RIOT 2000
- ACLX 2015
- Country
- RIOT United States
- ACLX United States
- Employees
- RIOT N/A
- ACLX N/A
- Industry
- RIOT Retail: Computer Software & Peripheral Equipment
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- RIOT Technology
- ACLX Health Care
- Exchange
- RIOT Nasdaq
- ACLX Nasdaq
- Market Cap
- RIOT 4.0B
- ACLX 3.3B
- IPO Year
- RIOT N/A
- ACLX 2022
- Fundamental
- Price
- RIOT $7.41
- ACLX $67.96
- Analyst Decision
- RIOT Strong Buy
- ACLX Strong Buy
- Analyst Count
- RIOT 13
- ACLX 13
- Target Price
- RIOT $17.42
- ACLX $110.82
- AVG Volume (30 Days)
- RIOT 23.9M
- ACLX 617.2K
- Earning Date
- RIOT 04-30-2025
- ACLX 05-08-2025
- Dividend Yield
- RIOT N/A
- ACLX N/A
- EPS Growth
- RIOT N/A
- ACLX N/A
- EPS
- RIOT 0.34
- ACLX N/A
- Revenue
- RIOT $376,658,000.00
- ACLX $107,936,000.00
- Revenue This Year
- RIOT $94.00
- ACLX N/A
- Revenue Next Year
- RIOT $2.60
- ACLX $103.84
- P/E Ratio
- RIOT $21.53
- ACLX N/A
- Revenue Growth
- RIOT 34.20
- ACLX N/A
- 52 Week Low
- RIOT $6.36
- ACLX $47.88
- 52 Week High
- RIOT $15.87
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- RIOT 37.75
- ACLX 47.21
- Support Level
- RIOT $7.50
- ACLX $68.56
- Resistance Level
- RIOT $8.83
- ACLX $72.68
- Average True Range (ATR)
- RIOT 0.52
- ACLX 3.01
- MACD
- RIOT 0.12
- ACLX -0.31
- Stochastic Oscillator
- RIOT 10.69
- ACLX 18.14
About RIOT Riot Platforms Inc.
Riot Platforms Inc is a vertically integrated Bitcoin mining company focused on building, supporting, and operating blockchain technologies. The company's segments include Bitcoin Mining; Data Center Hosting and Engineering. It generates maximum revenue from the Bitcoin Mining segment which generates revenue from the Bitcoin the company earns through its mining activities.
About ACLX Arcellx Inc.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.